Dr. Reddy’s Laboratories Ltd. gets FDA approval for generic Allegra

Yahoo - Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) said on Thursday that it has received final approval from the Food and Drug Administration (FDA) for its generic version of allergy medication Allegra, and will begin commercial marketing immediately.

The stock is near its 52 week high but the downturn in the Indian market the last couple of days is clearly affecting the stock.

Related Articles
Posted on Thursday, April 13th, 2006 at 9:32 am In Dr. Reddy's | Comments RSS

Leave a Reply

India.FinancialNirvana.com

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 United States License.
Close
E-mail It